Obsessive-compulsive disorder
- PMID: 24576790
- DOI: 10.1177/0897190014521996
Obsessive-compulsive disorder
Abstract
Obsessive-compulsive disorder (OCD) is a common heterogeneous psychiatric disorder manifesting with obsessions and compulsions. Obsessions are intrusive, recurrent, and persistent unwanted thoughts. Compulsions are repetitive behaviors or mental acts that an individual feels driven to perform in response to the obsessions. The heterogeneity of OCD includes themes of obsessions, types of rituals, presence or absence of tics, etiology, genetics, and response to pharmacotherapy. Complications of OCD include interpersonal difficulties, unemployment, substance abuse, criminal justice issues, and physical injuries. Areas of the brain involved in the pathophysiology include the orbitofrontal cortex, anterior cingulate gyrus, and basal ganglia. Overall, OCD may be due to a malfunction in the cortico-striato-thalamo-cortical circuit in the brain. Neurotransmitters implicated in OCD include serotonin, dopamine, and glutamate. Numerous drugs such as atypical antipsychotics and dopaminergic agents can cause or exacerbate OCD symptoms. The etiology includes genetics and neurological insults. Treatment of OCD includes psychotherapy, pharmacotherapy, electroconvulsive therapy, transcranial magnetic simulation, and in extreme cases surgery. Exposure and response prevention is the most effective form of psychotherapy. Selective serotonin reuptake inhibitors (SSRIs) are the preferred pharmacotherapy. Higher doses than listed in the package insert and a longer trial are often needed for SSRIs than compared to other psychiatric disorders. Alternatives to SSRIs include clomipramine and serotonin/norepinephrine reuptake inhibitors. Treatment of resistant cases includes augmentation with atypical antipsychotics, pindolol, buspirone, and glutamate-blocking agents.
Keywords: exposure and response prevention; obsessive–compulsive disorder; psychiatry; psychopharmacology; serotonin reuptake inhibitors.
Similar articles
-
Recognition and treatment of obsessive-compulsive disorder.J Clin Psychiatry. 2007 Dec;68(12):e30. doi: 10.4088/jcp.1207e30. J Clin Psychiatry. 2007. PMID: 18162010 Review.
-
Obsessive-Compulsive Disorder.Continuum (Minneap Minn). 2018 Jun;24(3, BEHAVIORAL NEUROLOGY AND PSYCHIATRY):828-844. doi: 10.1212/CON.0000000000000603. Continuum (Minneap Minn). 2018. PMID: 29851880 Review.
-
Obsessive-compulsive disorder.Psychiatr Clin North Am. 2014 Sep;37(3):257-67. doi: 10.1016/j.psc.2014.06.004. Epub 2014 Jul 23. Psychiatr Clin North Am. 2014. PMID: 25150561 Review.
-
The Psychopharmacology of Obsessive-Compulsive Disorder: A Preclinical Roadmap.Pharmacol Rev. 2020 Jan;72(1):80-151. doi: 10.1124/pr.119.017772. Pharmacol Rev. 2020. PMID: 31826934 Review.
-
[Current and emerging features of obsessive-compulsive disorder--trends for the revision of DSM-5].Seishin Shinkeigaku Zasshi. 2012;114(9):1023-30. Seishin Shinkeigaku Zasshi. 2012. PMID: 23198591 Review. Japanese.
Cited by
-
Amelioration of obsessive-compulsive disorder by intracellular acidification of cortical neurons with a proton pump inhibitor.Transl Psychiatry. 2024 Jan 16;14(1):27. doi: 10.1038/s41398-024-02731-3. Transl Psychiatry. 2024. PMID: 38228604 Free PMC article.
-
Two distinct subtypes of obsessive compulsive disorder revealed by a framework integrating multimodal neuroimaging information.Hum Brain Mapp. 2022 Oct 1;43(14):4254-4265. doi: 10.1002/hbm.25951. Epub 2022 Jun 21. Hum Brain Mapp. 2022. PMID: 35726798 Free PMC article.
-
The Evaluation of Thiol/Disulfide Homeostasis and Oxidative DNA Damage in Patients with Obsessive Compulsive Disorder.Clin Psychopharmacol Neurosci. 2022 May 31;20(2):240-247. doi: 10.9758/cpn.2022.20.2.240. Clin Psychopharmacol Neurosci. 2022. PMID: 35466095 Free PMC article.
-
Two distinct subtypes of obsessive compulsive disorder revealed by heterogeneity through discriminative analysis.Hum Brain Mapp. 2022 Jul;43(10):3037-3046. doi: 10.1002/hbm.25833. Epub 2022 Apr 5. Hum Brain Mapp. 2022. PMID: 35384125 Free PMC article.
-
Asymmetry in the Central Nervous System: A Clinical Neuroscience Perspective.Front Syst Neurosci. 2021 Dec 14;15:733898. doi: 10.3389/fnsys.2021.733898. eCollection 2021. Front Syst Neurosci. 2021. PMID: 34970125 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical